312 related articles for article (PubMed ID: 11315989)
21. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory and stimulatory effects of dexamethasone and 1,25-dihydroxyvitamin D3 on chick intestinal calbindin-D28K and its mRNA.
Hall AK; Bishop JE; Norman AW
Mol Cell Endocrinol; 1987 May; 51(1-2):25-31. PubMed ID: 3036623
[TBL] [Abstract][Full Text] [Related]
23. Modulation of quail intestinal and egg shell gland calbindin (Mr 28,000) gene expression by vitamin D3, 1,25-dihydroxyvitamin D3 and egg laying.
Striem S; Bar A
Mol Cell Endocrinol; 1991 Feb; 75(2):169-77. PubMed ID: 1646742
[TBL] [Abstract][Full Text] [Related]
24. Molecular aspects of the calbindins.
Christakos S; Gill R; Lee S; Li H
J Nutr; 1992 Mar; 122(3 Suppl):678-82. PubMed ID: 1542030
[TBL] [Abstract][Full Text] [Related]
25. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
26. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
Reinhardt TA; Horst RL
Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
[TBL] [Abstract][Full Text] [Related]
27. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion.
Lee S; Clark SA; Gill RK; Christakos S
Endocrinology; 1994 Apr; 134(4):1602-10. PubMed ID: 8137721
[TBL] [Abstract][Full Text] [Related]
28. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM
Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
Chen ML; Ray S; Swamy N; Holick MF; Ray R
Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
[TBL] [Abstract][Full Text] [Related]
30. Dietary restriction of calcium, phosphorus, and vitamin D elicits differential regulation of the mRNAs for avian intestinal calbindin-D28k and the 1,25-dihydroxyvitamin D3 receptor.
Meyer J; Fullmer CS; Wasserman RH; Komm BS; Haussler MR
J Bone Miner Res; 1992 Apr; 7(4):441-8. PubMed ID: 1376958
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of calbindin-D9K (CaBP9K) gene expression by calcium and 1,25-dihydroxycholecalciferol in fetal rat duodenal organ culture.
Brehier A; Thomasset M
Endocrinology; 1990 Aug; 127(2):580-7. PubMed ID: 1695565
[TBL] [Abstract][Full Text] [Related]
32. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3.
Stephanou A; Ross R; Handwerger S
Endocrinology; 1994 Dec; 135(6):2651-6. PubMed ID: 7988455
[TBL] [Abstract][Full Text] [Related]
35. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line.
Wood RJ; Tchack L; Taparia S
BMC Physiol; 2001; 1():11. PubMed ID: 11545681
[TBL] [Abstract][Full Text] [Related]
37. The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine.
Yamamoto H; Miyamoto K; Li B; Taketani Y; Kitano M; Inoue Y; Morita K; Pike JW; Takeda E
J Bone Miner Res; 1999 Feb; 14(2):240-7. PubMed ID: 9933478
[TBL] [Abstract][Full Text] [Related]
38. Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon.
Schwartz B; Smirnoff P; Shany S; Liel Y
Mol Cell Biochem; 2000 Jan; 203(1-2):87-93. PubMed ID: 10724336
[TBL] [Abstract][Full Text] [Related]
39. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.
Hedlund TE; Moffatt KA; Miller GJ
Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485
[TBL] [Abstract][Full Text] [Related]
40. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
